EMERYVILLE, Calif., July 26, 2024--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the "Company" or "NovaBay"), today announced the pricing of its underwritten public offering of ...
Source LinkEMERYVILLE, Calif., July 26, 2024--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the "Company" or "NovaBay"), today announced the pricing of its underwritten public offering of ...
Source Link
Comments